Gene Activity List

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 7 of 1714:
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Gene Compound Assay Inh Ic50 Ki View
sodium channel, voltage-gated, type IV, beta TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
sodium channel associated protein 1 TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
sodium channel associated protein 2 TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
sodium channel, voltage-gated, type III, beta TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
sodium channel, voltage-gated, type I, alpha TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
sodium channel, voltage-gated, type IX, alpha TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
sodium channel, voltage-gated, type VII, alpha TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
amiloride-sensitive cation channel 5, intestinal TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
sodium channel, voltage-gated, type III, beta TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
sodium channel, voltage-gated, type XI, alpha TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
sodium channel, voltage-gated, type I, beta TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
sodium channel, voltage-gated, type 10, alpha polypeptide TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
sodium channel, voltage-gated, type IV, alpha polypeptide TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
sodium channel, voltage-gated, type V, alpha polypeptide TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
sodium channel, voltage-gated, type II, beta TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
sodium channel, nonvoltage-gated 1 alpha TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
sodium channel, nonvoltage-gated 1 gamma TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
sodium channel, nonvoltage-gated 1 beta TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
sodium channel, voltage-gated, type XI, alpha TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
sodium channel, nonvoltage-gated 1, gamma TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
sodium channel, nonvoltage-gated 1, delta TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
sodium channel, nonvoltage-gated 1 alpha TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
sodium channel, voltage-gated, type X, alpha TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
sodium channel, voltage-gated, type IX, alpha TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
sodium channel, voltage gated, type VIII, alpha TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
sodium channel, voltage-gated, type VII, alpha TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
sodium channel, voltage-gated, type IV, beta TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
sodium channel, voltage-gated, type IV, alpha TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
sodium channel, voltage-gated, type III, alpha TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
sodium channel, voltage-gated, type II, beta TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
sodium channel, voltage-gated, type II, alpha 2 TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
sodium channel, voltage-gated, type I, beta TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
sodium channel, voltage-gated, type I, alpha TAMOXIFEN Sodium Channel, Site 2 100% 1.272uM 1.14uM View
Protein-tyrosine kinase, Fyn TAMOXIFEN Protein Tyrosine Kinase, Fyn 100% 1.195uM NoneNone View
nuclear receptor subfamily 3, group C, member 1 TRIAMCINOLONE ACETONIDE Glucocorticoid 100% .004414uM .002006uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 TAMOXIFEN Dopamine Transporter 100% 1.841uM 1.462uM View
cholinergic receptor, muscarinic 3 TAMOXIFEN Muscarinic M3 100% 2.974uM .63uM View
tachykinin receptor 2 TAMOXIFEN Tachykinin NK2 100% 3.67uM 1.223uM View
adrenergic receptor, alpha 1b TERAZOSIN Adrenergic alpha1B 100% .006025uM .003335uM View
cholinergic receptor, muscarinic 2 TAMOXIFEN Muscarinic M2 100% 7.793uM 2.771uM View
prostaglandin-endoperoxide synthase 1 TAMOXIFEN Cyclooxygenase COX-1 100% 4.391uM NoneNone View
Sigma-2 Receptor VERAPAMIL Sigma2 74% 2.824uM 1.738uM View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) TAMOXIFEN Cyclooxygenase COX-1 100% 4.391uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 2B DIHYDROERGOTAMINE Serotonin 5-HT2B 100% .006804uM .00433uM View
5-hydroxytryptamine (serotonin) receptor 1A YOHIMBINE Serotonin 5-HT1A 100% .126uM .072uM View
adrenergic receptor, alpha 2b DIHYDROERGOTAMINE Adrenergic alpha2B 100% .003867uM .001766uM View
dopamine receptor D3 TAMOXIFEN Dopamine D3 100% 1.072uM .364uM View
5-hydroxytryptamine (serotonin) receptor 1B DIHYDROERGOTAMINE Serotonin 5-HT1B 100% .000846uM .000384uM View
5-hydroxytryptamine (serotonin) receptor 5B DIHYDROERGOTAMINE Serotonin 5-HT4 100% .94uM .157uM View
5-hydroxytryptamine (serotonin) receptor 4 DIHYDROERGOTAMINE Serotonin 5-HT4 100% .94uM .157uM View
5-hydroxytryptamine receptor 6 DIHYDROERGOTAMINE Serotonin 5-HT6 100% .003201uM .001486uM View
adrenergic receptor, alpha 1d (Non-specific probe) TERAZOSIN Adrenergic alpha1D 100% .017uM .008363uM View
adrenergic receptor, alpha 1a TERAZOSIN Adrenergic alpha1A 100% .024uM .009592uM View
cholinergic receptor, muscarinic 5 DICYCLOMINE Muscarinic M5 100% .002382uM .001711uM View
adrenergic receptor, alpha 1a CISAPRIDE Adrenergic alpha1A 100% .12uM .049uM View
sodium channel, voltage-gated, type IV, beta CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
sodium channel associated protein 1 CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
sodium channel associated protein 2 CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
sodium channel, voltage-gated, type III, beta CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
sodium channel, voltage-gated, type I, alpha CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
sodium channel, voltage-gated, type IX, alpha CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
sodium channel, voltage-gated, type VII, alpha CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
amiloride-sensitive cation channel 5, intestinal CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
sodium channel, voltage-gated, type III, beta CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
sodium channel, voltage-gated, type XI, alpha CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
sodium channel, voltage-gated, type I, beta CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
sodium channel, voltage-gated, type 10, alpha polypeptide CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
sodium channel, voltage-gated, type IV, alpha polypeptide CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
sodium channel, voltage-gated, type V, alpha polypeptide CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
sodium channel, voltage-gated, type II, beta CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
sodium channel, nonvoltage-gated 1 alpha CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
sodium channel, nonvoltage-gated 1 gamma CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
sodium channel, nonvoltage-gated 1 beta CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
sodium channel, voltage-gated, type XI, alpha CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
sodium channel, nonvoltage-gated 1, gamma CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
sodium channel, nonvoltage-gated 1, delta CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
sodium channel, nonvoltage-gated 1 alpha CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
sodium channel, voltage-gated, type X, alpha CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
sodium channel, voltage-gated, type IX, alpha CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
sodium channel, voltage gated, type VIII, alpha CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
sodium channel, voltage-gated, type VII, alpha CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
sodium channel, voltage-gated, type IV, beta CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
prostaglandin-endoperoxide synthase 2 R(-)-IBUPROFEN Cyclooxygenase COX-2 27% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
sodium channel, voltage-gated, type III, alpha CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
sodium channel, voltage-gated, type II, beta CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
sodium channel, voltage-gated, type II, alpha 2 CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
sodium channel, voltage-gated, type I, beta CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
sodium channel, voltage-gated, type I, alpha CISAPRIDE Sodium Channel, Site 2 100% 1.109uM 1.012uM View
adrenergic receptor, alpha 1b CISAPRIDE Adrenergic alpha1B 100% .016uM .008654uM View
dopamine receptor D3 ERGONOVINE Dopamine D3 100% .567uM .193uM View
calcium channel, voltage-dependent, gamma subunit 8 NIFEDIPINE Calcium Channel Type L, Dihydropyridine 100% .048uM .031uM View
sodium channel, voltage-gated, type III, beta CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
sodium channel, voltage-gated, type XI, alpha CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
sodium channel, voltage-gated, type I, beta CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
sodium channel, voltage-gated, type 10, alpha polypeptide CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
sodium channel, voltage-gated, type IV, alpha polypeptide CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
sodium channel, voltage-gated, type V, alpha polypeptide CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
sodium channel, voltage-gated, type II, beta CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
sodium channel, nonvoltage-gated 1 alpha CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
sodium channel, nonvoltage-gated 1 gamma CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
sodium channel, nonvoltage-gated 1 beta CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
sodium channel, voltage-gated, type XI, alpha CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
sodium channel, nonvoltage-gated 1, gamma CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
sodium channel, nonvoltage-gated 1, delta CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
sodium channel, nonvoltage-gated 1 alpha CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
sodium channel, voltage-gated, type X, alpha CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
sodium channel, voltage-gated, type IX, alpha CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
sodium channel, voltage gated, type VIII, alpha CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
sodium channel, voltage-gated, type VII, alpha CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
sodium channel, voltage-gated, type IV, beta CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
sodium channel, voltage-gated, type IV, alpha CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
sodium channel, voltage-gated, type III, alpha CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
sodium channel, voltage-gated, type II, beta CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
sodium channel, voltage-gated, type II, alpha 2 CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
sodium channel, voltage-gated, type I, beta CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
sodium channel, voltage-gated, type I, alpha CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
3-hydroxy-3-methylglutaryl-Coenzyme A reductase ATORVASTATIN HMG-CoA Reductase 100% .000227uM NoneNone View
3-hydroxy-3-methylglutaryl-Coenzyme A reductase ATORVASTATIN HMG-CoA Reductase 100% .000227uM NoneNone View
5-hydroxytryptamine receptor 6 ERGONOVINE Serotonin 5-HT6 100% .003237uM .001503uM View
cholinergic receptor, muscarinic 4 ATROPINE Muscarinic M4 100% .000744uM .000104uM View
cholinergic receptor, muscarinic 3 ATROPINE Muscarinic M3 100% .002071uM .000439uM View
sodium channel, voltage-gated, type II, beta CARVEDILOL Sodium Channel, Site 2 100% .455uM .415uM View
sodium channel, nonvoltage-gated 1 alpha CARVEDILOL Sodium Channel, Site 2 100% .455uM .415uM View
sodium channel, nonvoltage-gated 1 gamma CARVEDILOL Sodium Channel, Site 2 100% .455uM .415uM View
sodium channel, nonvoltage-gated 1 beta CARVEDILOL Sodium Channel, Site 2 100% .455uM .415uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide CARVEDILOL Sodium Channel, Site 2 100% .455uM .415uM View
sodium channel, voltage-gated, type XI, alpha CARVEDILOL Sodium Channel, Site 2 100% .455uM .415uM View
sodium channel, nonvoltage-gated 1, gamma CARVEDILOL Sodium Channel, Site 2 100% .455uM .415uM View
sodium channel, nonvoltage-gated 1, delta CARVEDILOL Sodium Channel, Site 2 100% .455uM .415uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) CARVEDILOL Sodium Channel, Site 2 100% .455uM .415uM View
sodium channel, nonvoltage-gated 1 alpha CARVEDILOL Sodium Channel, Site 2 100% .455uM .415uM View
sodium channel, voltage-gated, type X, alpha CARVEDILOL Sodium Channel, Site 2 100% .455uM .415uM View
sodium channel, voltage-gated, type IX, alpha CARVEDILOL Sodium Channel, Site 2 100% .455uM .415uM View
sodium channel, voltage gated, type VIII, alpha CARVEDILOL Sodium Channel, Site 2 100% .455uM .415uM View
sodium channel, voltage-gated, type VII, alpha CARVEDILOL Sodium Channel, Site 2 100% .455uM .415uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) CARVEDILOL Sodium Channel, Site 2 100% .455uM .415uM View
sodium channel, voltage-gated, type IV, beta CARVEDILOL Sodium Channel, Site 2 100% .455uM .415uM View
sodium channel, voltage-gated, type IV, alpha CARVEDILOL Sodium Channel, Site 2 100% .455uM .415uM View
sodium channel, voltage-gated, type III, alpha CARVEDILOL Sodium Channel, Site 2 100% .455uM .415uM View
sodium channel, voltage-gated, type II, beta CARVEDILOL Sodium Channel, Site 2 100% .455uM .415uM View
sodium channel, voltage-gated, type II, alpha 2 CARVEDILOL Sodium Channel, Site 2 100% .455uM .415uM View
calcium channel, voltage-dependent, gamma subunit 7 NIFEDIPINE Calcium Channel Type L, Dihydropyridine 100% .048uM .031uM View
calcium channel, voltage-dependent, gamma subunit 6 NIFEDIPINE Calcium Channel Type L, Dihydropyridine 100% .048uM .031uM View
calcium channel, voltage-dependent, gamma subunit 5 NIFEDIPINE Calcium Channel Type L, Dihydropyridine 100% .048uM .031uM View
calcium channel, voltage-dependent, gamma subunit 4 NIFEDIPINE Calcium Channel Type L, Dihydropyridine 100% .048uM .031uM View
calcium channel, voltage-dependent, gamma subunit 3 NIFEDIPINE Calcium Channel Type L, Dihydropyridine 100% .048uM .031uM View
calcium channel, voltage-dependent, gamma subunit 2 NIFEDIPINE Calcium Channel Type L, Dihydropyridine 100% .048uM .031uM View
calcium channel, voltage-dependent, gamma subunit 1 NIFEDIPINE Calcium Channel Type L, Dihydropyridine 100% .048uM .031uM View
calcium channel, voltage-dependent, beta 4 subunit NIFEDIPINE Calcium Channel Type L, Dihydropyridine 100% .048uM .031uM View
calcium channel, voltage-dependent, beta 3 subunit NIFEDIPINE Calcium Channel Type L, Dihydropyridine 100% .048uM .031uM View
calcium channel, voltage-dependent, beta 2 subunit NIFEDIPINE Calcium Channel Type L, Dihydropyridine 100% .048uM .031uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit NIFEDIPINE Calcium Channel Type L, Dihydropyridine 100% .048uM .031uM View
calcium channel, voltage-dependent, alpha 1F subunit NIFEDIPINE Calcium Channel Type L, Dihydropyridine 100% .048uM .031uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit NIFEDIPINE Calcium Channel Type L, Dihydropyridine 100% .048uM .031uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit NIFEDIPINE Calcium Channel Type L, Dihydropyridine 100% .048uM .031uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit NIFEDIPINE Calcium Channel Type L, Dihydropyridine 100% .048uM .031uM View
calcium channel, voltage-dependent, beta 1 subunit NIFEDIPINE Calcium Channel Type L, Dihydropyridine 100% .048uM .031uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit NIFEDIPINE Calcium Channel Type L, Dihydropyridine 100% .048uM .031uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit NIFEDIPINE Calcium Channel Type L, Dihydropyridine 100% .048uM .031uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 NIFEDIPINE Calcium Channel Type L, Dihydropyridine 100% .048uM .031uM View
cholinergic receptor, muscarinic 4 DICYCLOMINE Muscarinic M4 100% .002947uM .000411uM View
5-hydroxytryptamine (serotonin) receptor 1B ERGONOVINE Serotonin 5-HT1B 100% .002845uM .001293uM View
adrenergic receptor, alpha 2b ERGONOVINE Adrenergic alpha2B 100% .289uM .132uM View
sodium channel, voltage-gated, type X, alpha CLOMIPRAMINE Sodium Channel, Site 2 100% .742uM .677uM View
sodium channel, voltage-gated, type IX, alpha CLOMIPRAMINE Sodium Channel, Site 2 100% .742uM .677uM View
sodium channel, voltage gated, type VIII, alpha CLOMIPRAMINE Sodium Channel, Site 2 100% .742uM .677uM View
sodium channel, voltage-gated, type VII, alpha CLOMIPRAMINE Sodium Channel, Site 2 100% .742uM .677uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) CLOMIPRAMINE Sodium Channel, Site 2 100% .742uM .677uM View
sodium channel, voltage-gated, type IV, beta CLOMIPRAMINE Sodium Channel, Site 2 100% .742uM .677uM View
sodium channel, voltage-gated, type IV, alpha CLOMIPRAMINE Sodium Channel, Site 2 100% .742uM .677uM View
sodium channel, voltage-gated, type III, alpha CLOMIPRAMINE Sodium Channel, Site 2 100% .742uM .677uM View
sodium channel, voltage-gated, type II, beta CLOMIPRAMINE Sodium Channel, Site 2 100% .742uM .677uM View
sodium channel, voltage-gated, type II, alpha 2 CLOMIPRAMINE Sodium Channel, Site 2 100% .742uM .677uM View
sodium channel, voltage-gated, type I, beta CLOMIPRAMINE Sodium Channel, Site 2 100% .742uM .677uM View
sodium channel, voltage-gated, type I, alpha CLOMIPRAMINE Sodium Channel, Site 2 100% .742uM .677uM View
cholinergic receptor, muscarinic 1 CLOMIPRAMINE Muscarinic M1 100% .091uM .022uM View
5-hydroxytryptamine (serotonin) receptor 5B CISAPRIDE Serotonin 5-HT4 100% .273uM .045uM View
5-hydroxytryptamine (serotonin) receptor 4 CISAPRIDE Serotonin 5-HT4 100% .273uM .045uM View
adrenergic receptor, beta 2 CLENBUTEROL Adrenergic beta2 100% .041uM .028uM View
adrenergic receptor, alpha 1b CLEMASTINE Adrenergic alpha1B 100% .074uM .041uM View
5-hydroxytryptamine (serotonin) receptor 2A CLEMASTINE Serotonin 5-HT2A 100% .032uM .009196uM View
dopamine receptor D3 CLEMASTINE Dopamine D3 100% .007335uM .002491uM View
5-hydroxytryptamine receptor 6 CLEMASTINE Serotonin 5-HT6 100% .077uM .036uM View
adrenergic receptor, alpha 1a CLEMASTINE Adrenergic alpha1A 100% .053uM .021uM View
adrenergic receptor, alpha 2a CLEMASTINE Adrenergic alpha2A 100% .183uM .069uM View
sodium channel, voltage-gated, type IV, beta CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
sodium channel associated protein 1 CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View